Flotek Industries, Inc. Announces Fourth Quarter 2017 Results

HOUSTON, Feb. 20, 2018 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the three and twelve months ended December 31, 2017.

Highlights

    --  GAAP earnings (loss) per share ("EPS") from continuing operations of
        ($0.14) and ($0.23) for the three and twelve months ended December 31,
        2017, respectively; compared to $0.07 and $0.03 for the three and twelve
        months ended December 31, 2016, respectively.
    --  Adjusted EPS from continuing operations of $0.00 and ($0.07) for the
        three and twelve months ended December 31, 2017, respectively; compared
        to ($0.07) and ($0.11) for the three and twelve months ended December
        31, 2016, respectively.
    --  Full year 2017 revenue increased 20.6% year-over-year to $317.1 million.
        Fourth quarter 2017 revenue declined 8.7% sequentially to $72.5 million
        and increased 2.7% year-over-year.
    --  Cash SG&A of $14.5 million (excluding stock compensation expense of $1.5
        million) in the fourth quarter 2017, under the low end of the Company's
        guidance of $15.0 million - $16.0 million, decreased 25% compared to
        fourth quarter 2016 levels, ahead of its 20% y/y reduction target.
    --  Net income (loss) from continuing operations of ($7.8) million for the
        fourth quarter 2017, compared to ($3.4) million for the third quarter
        2017 and $3.9 million in the fourth quarter 2016.
    --  Adjusted EBITDA, a non-GAAP measure, of $7.7 million for the fourth
        quarter 2017, compared to $3.3 million in the third quarter 2017 and
        $0.7 million in the fourth quarter 2016.
    --  Fourth quarter 2017 free cash flow (operating cash flow less capital
        expenditures) of $13.1 million, compared to $6.8 million in third
        quarter 2017 and ($0.5) million in fourth quarter 2016.
    --  Decreased net debt position by 46.4% year-over-year to $23.4 million at
        year end 2017.

(Please refer to GAAP reconciliation tables in this release)

John Chisholm, Flotek's Chairman, President and Chief Executive Officer commented, "Last year was a transformational year for Flotek, as we undertook several measures to improve our market position and profitability. First, during 2017, our management team was transformed to reflect the future of Flotek, and we are excited about the strength of our leadership team as we enter 2018 as a re-defined organization. Second, in May, we completed the Drilling Technologies and Production Technologies segment divestitures which have improved our free cash flow profile. Third, we paid down the balance of our term loan and increased the availability of our revolver while extending its maturity by two years. Our total debt at year end 2017 was $28.0 million, down 42% from $48.4 million at year end 2016. Fourth, we initiated a thorough review of our SG&A with a targeted run-rate reduction of 20% from 4Q16 levels. Our 4Q17 cash SG&A achieved a 25% reduction. Through it all, we have remained committed to our Research and Innovation, which continues to introduce new products into the market specifically to meet the requirements and needs of both E&P operators and service companies who remain integral in the efficient distribution channels into the industry.

"During the fourth quarter 2017, our Energy Chemistry Technologies ("ECT") segment experienced a slower than anticipated December month, largely due to weather events, budget exhaustion and seasonal factors which we alluded to in our guidance last quarter. Despite the industry related operational issues and subsequently lower revenues, our recent focus on cost control led to the highest quarterly segment profitability at the EBITDA and operating income lines for the year. As an organization, we are proud of the progress and execution we have made on this front, which was laid out on our third quarter 2017 call, and which I attribute to the quality and effort of our employees.

"Additionally, we have begun increasing our marketing efforts through the release of a series of case studies. Most recently, we released a study evaluating a sample of 426 Midland Basin wells targeting the Wolfcamp B interval. Wells with our Complex nano-Fluid® technology improved cumulative barrels of oil equivalent (BOE) over the first 12 months of production by 22% after normalizing for proppant amount and perforated length. We will continue to provide insight into the success E&P operators experience in utilizing Flotek's custom chemistry solutions going forward. Our focus remains on improving reservoir performance and recovery factors which makes a difference to our clients' economics and provides consistent and reliable chemistry technology to operators and service companies alike.

"Our Consumer and Industrial Chemistry Technologies ("CICT") segment continued to perform well despite a volatile citrus market, which remains impacted by lower crop yields due to disease and hurricane activity. Fourth quarter revenues were in line with our guidance and represent an 11.3% year-over-year improvement. During the fourth quarter we completed the installation of a new vacuum distillation unit in Winter Haven, FL, and we continue to invest in improving our facilities and market position in our CICT segment.

"As a result of reducing our debt, we have bolstered our financial position. Our only debt today consists of our revolver borrowings, which is primarily being used to fund working capital. Our balance sheet gives us the flexibility to remain opportunistic moving forward as we execute our plans to grow in the custom chemistry marketplace, both in ECT and CICT. We will also continue to evaluate further stock buybacks but believe our runway of growth opportunities requires disciplined investment to preserve our strong balance sheet and liquidity position.

"Looking ahead, I am very excited about our opportunities, our employees are dedicated, and our focus remains on serving our clients the best we can by offering new technology at competitive prices. The measures we are undertaking to control our costs, leverage our R&I capability for new product development and align ourselves with our clients is designed to have a measurable, positive impact to shareholder value in the long run."

Full Year 2017 Results

For the twelve months ended December 31, 2017, Flotek reported revenue of $317.1 million, an increase of $54.3 million, or 20.6%, compared to $262.8 million in 2016.

Flotek reported income (loss) from continuing operations for the twelve months ended December 31, 2017 of ($13.1) million, a decrease of $15.0 million compared to $1.9 million in 2016. On a GAAP basis, Flotek reported income (loss) per share (fully diluted) for the twelve months ended December 31, 2017 of ($0.23) from continuing operations compared to $0.03 for the twelve months ended December 31, 2016.

Excluding select items, comprised primarily of executive retirement/severance expense and the impact of the U.S. Tax Cuts & Jobs Act of 2017 to income tax expense totaling $9.2 million, net of tax, or $0.16 per share, adjusted EPS from continuing operations was ($0.07) for the twelve months ended December 31, 2017, compared to ($0.11) for the twelve months ended December 31, 2016. (See our Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") for the twelve months ended December 31, 2017, was $10.1 million, compared to $15.6 million for the twelve months ended December 31, 2016. Adjusted EBITDA, which excludes select items comprised primarily of stock compensation expense, gain on sale of assets and executive retirement/severance expense, for the full year 2017 was $23.5 million, compared to full year 2016 adjusted EBITDA of $14.9 million. Management believes that adjusted EBITDA provides useful information to investors to better assess and understand operating performance and cash flows. (See our Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

Fourth Quarter 2017 Results

For the three months ended December 31, 2017, Flotek reported revenue of $72.5 million, an increase of $1.9 million, or 2.7%, compared to $70.6 million in the same period of 2016. Revenue decreased $6.9 million, or 8.7%, compared to the third quarter of 2017.

Flotek reported income (loss) from continuing operations for the three months ended December 31, 2017 of ($7.8) million, a decrease of $11.7 million compared to $3.9 million in the same period of 2016. Income (loss) from continuing operations decreased $4.3 million compared to third quarter 2017. On a GAAP basis, Flotek reported income (loss) per share (fully diluted) from continuing operations for the three months ended December 31, 2017 of ($0.14) compared to $0.07 for the three months ended December 31, 2016.

Excluding select items, comprised primarily of executive retirement/severance expense and the impact of the U.S. Tax Cuts & Jobs Act of 2017 to income tax expense totaling $8.0 million, net of tax, or $0.14 per share, adjusted EPS from continuing operations was $0.00 for the three months ended December 31, 2017, compared to ($0.07) for the three months ended December 31, 2016. (See our Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

EBITDA for the three months ended December 31, 2017, was $5.3 million, compared to $10.0 million for the three months ended December 31, 2016. Adjusted EBITDA, which excludes select items comprised primarily of stock compensation expense, gain on sale of assets and executive retirement/severance expense, was $7.7 million compared to fourth quarter 2016 adjusted EBITDA of $0.7 million and third quarter 2017 adjusted EBITDA of $3.3 million. Management believes that adjusted EBITDA provides useful information to investors to better assess and understand operating performance and cash flows. (See our Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

A summary income statement reflecting fourth quarter and full year results can be found at the conclusion of this release, as well as GAAP reconciliation tables.

Fourth Quarter 2017 - Segment Highlights




                4Q 2017                 3Q 2017                  % Change          4Q 2016          % Change
                -------                 -------                  --------          -------          --------

                                 Energy Chemistry Technologies ("ECT")
                                  ------------------------------------

    Revenue      $55.3 million           $61.2 million                    (9.6%)    $55.1 million               0.3%
    -------      -------------           -------------                     -----     -------------                ---

    Income From
     Operations   $8.9 million            $6.9 million                     29.5%     $7.2 million              23.2%
    -----------   ------------            ------------                      ----      ------------               ----

    Adj. EBITDA  $14.6 million           $11.7 million                     24.1%    $12.6 million              15.5%
    -----------  -------------           -------------                      ----     -------------               ----

    Adj. EBITDA
     Margin              26.4%                   19.2%                   716 bps            22.9%            347 bps
    -----------           ----                     ----                                        ----             -------

                     Consumer and Industrial Chemistry Technologies ("CICT")

    Revenue      $17.2 million           $18.3 million                    (5.9%)    $15.5 million              11.3%
    -------      -------------           -------------                     -----     -------------               ----

    Income From
     Operations   $1.6 million            $1.0 million                     58.3%     $1.2 million              34.9%
    -----------   ------------            ------------                      ----      ------------               ----

    Adj. EBITDA   $2.4 million            $1.9 million                     30.8%     $1.8 million              33.4%
    -----------   ------------            ------------                      ----      ------------               ----

    Adj. EBITDA
     Margin              14.1%                   10.2%                   397 bps            11.8%            235 bps
    -----------           ----                     ----                    -------             ----             -------


    * Percentages may be different when
     calculated due to rounding.

    ** Segment adj. EBITDA excludes stock
     based compensation, gain on sale of
     assets and R&I allocations.

Energy Chemistry Technologies Highlights (ECT):

    --  Full year 2017 revenue increased 29.2% year-over-year to $243.1 million.
    --  Fourth quarter revenue decreased 9.6% sequentially to $55.3 million, and
        increased 0.3% year-over-year.
    --  Fourth quarter adjusted EBITDA margins increased by 716 basis points
        sequentially to 26.4% due to higher margin product sales, continued
        execution on cost controls and reduced pressure from hurricane related
        impacts.
    --  Fourth quarter adjusted EBITDA margins increased 347 basis points
        year-over-year due to cost controls.

Consumer and Industrial Chemistry Technologies Highlights (CICT):

    --  Full year CICT revenue decreased 0.8% year-over-year to $74.0 million.
    --  Fourth quarter CICT revenue decreased 5.9% sequentially to $17.2
        million, and increased 11.3% year-over-year.
    --  Fourth quarter CICT adjusted EBITDA margins increased by 397 basis
        points sequentially to 14.1% due to higher margin product sales and
        reduced pressure on citrus price inflation following Hurricane Irma in
        the third quarter. Fourth quarter adjusted EBITDA margins increased 235
        basis year-over-year due to higher margin product sales.

Balance Sheet and Liquidity

Net Debt decreased 34.5% from $35.6 million to $23.4 million, sequentially, and decreased 46.4% year-over-year from $43.6 million at year end 2016. Working capital benefits were $9.5 million for the fourth quarter 2017, primarily driven by reduction in Accounts Receivable. Total liquidity at quarter end was $48.5 million. The balance on our credit facility as of December 31, 2017 was $28.0 million, compared to $40.6 million at the end of the third quarter and was $37.2 million as of 2/12/2018. We expect to fund working capital, as customary with our inventory purchases, during the front half of 2018.

Other Financial Items

    --  During the fourth quarter 2017, we incurred $7.3 million of tax expenses
        as a result of changes under the U.S. Tax Cuts & Jobs Act of 2017; as
        well as $0.7 million (net of taxes) related to executive
        retirement/severance expenses.
    --  Beginning with this release, cost of revenue shown on the Income
        Statement is no longer inclusive of any portion of depreciation &
        amortization, as was the case in prior period financials. As a result,
        depreciation & amortization on the Income Statement will now be
        consistent with the balances in the Cash Flow Statement.
    --  Due to competitive reasons, in future periods we will no longer disclose
        the detail of CnF® revenues and volumes which we have provided in past
        releases. This will better align with the ECT segment as a holistic
        custom chemistry solution provider to the oil & gas industry.
    --  Finally, segment gross margins are no longer reported for similar
        competitive reasons; however, we intend to continue to report segment
        operating income and adjusted EBITDA.

Flotek Outlook

In commenting about Flotek's outlook, Mr. Chisholm added, "With respect to our ECT segment, the oil and gas industry is shaping up for a stable operating environment moving into 2018. To date, operators appear to be acting with a degree of financial discipline and a renewed focus on returns over growth. Disciplined spending behavior, logistics challenges and weather delays in major basins during the start of the year are likely to lead to a more flattish environment in completions activity in 1Q18 sequentially, however the quarter will be dependent upon how quickly activity can return to pre-December levels. In our CICT segment, we expect revenues to increase sequentially and be flat to up year-over-year. Our SG&A reductions achieved through our cost cutting initiative should largely remain as we progress through the year. We anticipate capital spending to be in the $12 million to $16 million range for 2018 and will continue to manage our investments with a focus on our operating cash flows."

Conference Call Details

Flotek will host a conference call on Wednesday, February 21, at 9:30 AM CT (10:30 AM ET) to discuss its operating results for the three and twelve months ended December 31, 2017. To participate in the call, participants should dial 800-768-8804 approximately 5 minutes prior to the start of the call. The call can also be accessed from Flotek's website at www.flotekind.com.

About Flotek Industries, Inc.

Flotek develops and delivers prescriptive chemistry-based technology, including specialty chemicals, to clients in the energy, consumer industrials and food & beverage industries. Flotek's inspired chemists draw from the power of bio-derived solvents to deliver solutions that enhance energy production, cleaning products, foods & beverages and fragrances. In the oil and gas sector, Flotek serves major and independent energy producers and oilfield service companies, both domestic and international. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit Flotek's web site at www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this Press Release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this Press Release.

Although forward-looking statements in this Press Release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, demand for oil and natural gas drilling services in the areas and markets in which the Company operates, competition, obsolescence of products and services, the Company's ability to obtain financing to support its operations, environmental and other casualty risks, and the impact of government regulation.

Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filings on Form 10-K (including without limitation in the "Risk Factors" Section), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Press Release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Press Release.


                                                                              Flotek Industries, Inc.

                                                                  Unaudited Condensed Consolidated Balance Sheets

                                                                         (in thousands, except share data)


                                                                              December 31, 2017                   December 31, 2016
                                                                              -----------------                   -----------------

                           ASSETS

    Current assets:

    Cash and cash equivalents                                                                              $4,584                      $4,823

    Accounts receivable, net of
     allowance for doubtful accounts
     of $733 and $664 at December 31,
     2017 and December 31, 2016,
     respectively                                                                                          46,018                      47,152

    Inventories                                                                                            75,759                      58,283

    Income taxes receivable                                                                                 2,826                      12,752

    Assets held for sale                                                                                        -                     43,900

    Other current assets                                                                                    9,264                      21,708
                                                                                                            -----                      ------

    Total current assets                                                                                  138,451                     188,618

    Property and equipment, net                                                                            73,833                      74,691

    Goodwill                                                                                               56,660                      56,660

    Deferred tax assets, net                                                                               12,713                      12,894

    Other intangible assets, net                                                                           48,231                      50,352
                                                                                                           ------                      ------

    TOTAL ASSETS                                                                                         $329,888                    $383,215
                                                                                                         ========                    ========

                                               LIABILITIES AND EQUITY

    Current liabilities:

    Accounts payable                                                                                      $22,048                     $29,960

    Accrued liabilities                                                                                    14,589                      12,170

    Interest payable                                                                                           43                          24

    Liabilities held for sale                                                                                   -                      4,961

    Current portion of long-term debt                                                                      27,950                      40,566
                                                                                                           ------                      ------

    Total current liabilities                                                                              64,630                      87,681

    Long-term debt, less current
     portion                                                                                                    -                      7,833

    Total liabilities                                                                                      64,630                      95,514
                                                                                                           ------                      ------

    Commitments and contingencies

    Equity:

                                                                                                                -                          -

    Cumulative convertible preferred stock, $0.0001 par value, 100,000 shares authorized;
     no shares issued and outstanding

                                                                                                                6                           6



    Common stock, $0.0001 par value, 80,000,000 shares
     authorized; 60,622,986 shares issued and 56,755,293
     shares outstanding at December 31, 2017; 59,684,669
     shares issued and 56,972,580 shares outstanding at
     December 31, 2016

    Additional paid-in capital                                                                            336,067                     318,392

    Accumulated other comprehensive
     income (loss)                                                                                          (884)                      (956)

    Retained earnings (accumulated
     deficit)                                                                                            (37,225)                    (9,830)

    Treasury stock, at cost; 3,621,435 and 2,028,847 shares at December 31, 2017 and

    December 31, 2016, respectively                                                                      (33,064)                   (20,269)
                                                                                                          -------                     -------

    Flotek Industries, Inc.
     stockholders' equity                                                                                 264,900                     287,343

    Noncontrolling interests                                                                                  358                         358
                                                                                                              ---                         ---

    Total equity                                                                                          265,258                     287,701
                                                                                                          -------                     -------

    TOTAL LIABILITIES AND EQUITY                                                                         $329,888                    $383,215
                                                                                                         ========                    ========


                                                                                                 Flotek Industries, Inc.

                                                                                Unaudited Condensed Consolidated Statements of Operations

                                                                                          (in thousands, except per share data)


                                                    Three Months Ended                             Twelve Months Ended
                                                    ------------------                             -------------------

                                                                     12/31/2017                                     12/31/2016            12/31/2017   12/31/2016
                                                                     ----------                                     ----------            ----------   ----------

                                              (in thousands, except per share                (in thousands, except per share
                                                           data)                                          data)


    Revenue                                                             $72,509                                         $70,604               $317,098      $262,832


    Costs and expenses:

    Cost of revenue (excluding
     depreciation and
     amortization)                                                       47,739                                          47,249                215,129       170,254

    Corporate general and
     administrative                                                       7,719                                          13,347                 41,492        43,745

    Segment selling and
     administrative                                                       8,264                                           9,526                 37,236        36,405

    Depreciation and
     amortization                                                         3,068                                           3,049                 12,159        10,430

    Research and development                                              3,705                                           2,998                 13,645         9,320

    Loss (gain) on disposal of
     long-lived assets                                                    (109)                                             10                    292          (18)

    Total expenses                                                       70,386                                          76,179                319,953       270,136
                                                                         ------                                          ------                -------       -------

    Income (loss) from
     operations                                                           2,123                                         (5,575)               (2,855)      (7,304)

    Other (expense) income:

    Interest expense                                                      (450)                                          (443)               (2,168)      (1,979)

    Gain on legal settlement                                                  -                                         12,730                      -       12,730

    Other (expense) income, net                                             148                                           (209)                   812         (303)
                                                                            ---                                            ----                    ---          ----

    Total other (expense)
     income                                                               (302)                                         12,078                (1,356)       10,448
                                                                           ----                                          ------                 ------        ------

    (Loss) income before income
     taxes                                                                1,821                                           6,503                (4,211)        3,144

    Income tax expense                                                  (9,588)                                        (2,586)               (8,842)      (1,237)
                                                                         ------                                          ------                 ------        ------

    (Loss) income from
     continuing operations                                              (7,767)                                          3,917               (13,053)        1,907

    Loss from discontinued
     operations, net of tax                                               (722)                                       (17,836)              (14,342)     (51,037)

    Net  loss                                                          $(8,489)                                      $(13,919)             $(27,395)    $(49,130)
                                                                        =======                                        ========               ========      ========


    Basic earnings (loss) per common share:

    Continuing operations                                               $(0.14)                                          $0.07                $(0.23)        $0.03

    Discontinued operations,
     net of tax                                                          (0.01)                                         (0.31)                (0.25)       (0.91)

    Basic earnings (loss) per
     common share                                                       $(0.15)                                        $(0.24)               $(0.48)      $(0.88)
                                                                         ======                                          ======                 ======        ======

    Diluted earnings (loss) per common share:

    Continuing operations                                               $(0.14)                                          $0.07                $(0.23)        $0.03

    Discontinued operations,
     net of tax                                                          (0.01)                                         (0.31)                (0.25)       (0.91)

    Diluted earnings (loss) per
     common share                                                       $(0.15)                                        $(0.24)               $(0.48)      $(0.88)
                                                                         ======                                          ======                 ======        ======

    Weighted average common shares:

    Weighted average common
     shares used in computing
     basic earnings (loss) per
     common share                                                        57,196                                          57,768                 57,580        56,087

    Weighted average common
     shares used in computing
     diluted earnings (loss)
     per common share                                                    57,196                                          58,138                 57,580        56,350


                                                         Flotek Industries, Inc.

                                        Unaudited Condensed Consolidated Statements of Cash Flows

                                                              (in thousands)

                                                               Twelve Months Ended
                                                               -------------------

                                                                              12/31/2017          12/31/2016
                                                                              ----------          ----------

    Cash flows from operating activities:

    Net loss                                                                   $(27,395)           $(49,130)

    Loss from discontinued
     operations, net of tax                                                     (14,342)            (51,037)
                                                                                 -------              -------

    (Loss) income from continuing
     operations                                                                 (13,053)               1,907

    Adjustments to reconcile (loss) income from continuing operations
     to net cash provided by operating activities:

    Depreciation and amortization                                                 12,159               10,429

    Amortization of deferred
     financing costs                                                                 472                  424

    Provision for doubtful accounts                                                  124                  558

    Loss (gain) on sale of assets                                                    292                 (18)

    Stock compensation expense                                                    11,172               12,053

    Deferred income tax (benefit)
     provision                                                                       181             (19,681)

    Reduction in tax benefit related
     to share-based awards                                                         1,989                2,510

    Changes in current assets and liabilities:

    Accounts receivable, net                                                       1,445             (11,544)

    Inventories                                                                 (17,291)             (6,528)

    Income taxes receivable                                                        8,008              (8,189)

    Other current assets                                                          12,153             (14,489)

    Accounts payable                                                             (8,719)              12,653

    Accrued liabilities                                                            8,180               23,946

    Income taxes payable                                                               -             (1,890)

    Interest payable                                                                  19                 (87)

    Net cash provided by operating
     activities                                                                   17,131                2,054
                                                                                  ------                -----

    Cash flows from investing activities:

    Capital expenditures                                                         (8,960)            (13,960)

    Proceeds from sales of businesses                                             18,490                    -

    Proceeds from sale of assets                                                     689                  115

    Payments for acquisition, net of
     cash acquired                                                                     -             (7,863)

    Purchase of patents and other
     intangible assets                                                             (479)               (573)

    Net cash provided by (used in)
     investing activities                                                          9,740             (22,281)
                                                                                   -----              -------

    Cash flows from financing activities:

    Repayments of indebtedness                                                   (9,833)            (15,564)

    Borrowings on revolving credit
     facility                                                                    383,160              338,460

    Repayments on revolving credit
     facility                                                                  (393,776)           (325,043)

    Debt issuance costs                                                            (579)             (1,199)

    Reduction in tax benefit related
     to share-based awards                                                             -             (2,510)

    Purchase of treasury stock
     related to share-based awards                                               (1,729)             (2,350)

    Proceeds from sale of common
     stock                                                                           654               30,923

    Repurchase of common stock                                                   (5,203)                   -

    Proceeds from exercise of stock
     options                                                                          21                  134

    Net cash (used in) provided by
     financing activities                                                       (27,285)              22,851
                                                                                 -------               ------

    Discontinued operations:

    Net cash (used in) provided by
     operating activities                                                          (684)                  12

    Net cash provided by (used in)
     investing activities                                                            708                 (18)

    Net cash flows provided by (used
     in) discontinued operations                                                      24                  (6)
                                                                                     ---                  ---

    Effect of changes in exchange
     rates on cash and cash
     equivalents                                                                     151                  (3)
                                                                                     ---                  ---

    Net (decrease) increase in cash
     and cash equivalents                                                          (239)               2,615

    Cash and cash equivalents at the
     beginning of period                                                           4,823                2,208
                                                                                   -----                -----

    Cash and cash equivalents at the
     end of period                                                                $4,584               $4,823
                                                                                  ======               ======


                                                                                                            Flotek Industries, Inc.

                                                                                Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

                                                                                                     (in thousands, except per share data)


    GAAP Income (Loss) from Continuing Operations and Reconciliation to Adjusted Net Income (Loss) (Non-GAAP)
    --------------------------------------------------------------------------------------------------------


                                                                                                                                       Three Months Ended                          Twelve Months Ended
                                                                                                                                       ------------------                          -------------------

                                                                                    12/31/2017               12/31/2016                                   12/31/2017                                  12/31/2016
                                                                                    ----------               ----------                                   ----------                                  ----------

                                                                                                                                  (in thousands, except per share data)


    (Loss) Income from Continuing Operations (GAAP)                                   $(7,767)                   $3,917                                     $(13,053)                                      $1,907


                                                            Impact of 2017 Tax Act to
                                                            Income Tax Expense                       7,308                         -                                        7,308                                           -


                                                            Select Items Impacting
                                                            Earnings, net of tax                       657                   (8,275)                                        1,851                                     (8,275)


    Adjusted Net Income (Loss) (Non-GAAP)                                                 $198                  $(4,358)                                     $(3,894)                                    $(6,368)
                                                                                          ====                   =======                                       =======                                      =======


    Weighted Average Shares Outstanding (Fully Diluted)                                 57,196                    58,138                                        57,580                                       56,350


    Adjusted Earnings (Loss) Per Share (Fully
     Diluted)                                                                                        $0.00                   $(0.07)                                      $(0.07)                                    $(0.11)
                                                                                                     =====                    ======                                        ======                                      ======


    Select Items Impacting Earnings
    -------------------------------


                                                            Executive Retirement and Severance
                                                            Expense:

                                                            Stock
                                                            Compensation
                                                            Expense                                                               -                                            -                                        887                  -

                                                           Cash Payments                                                      1,011                                             -                                      1,961                  -


                                                            Gain on Legal
                                                            Settlement                                                            -                                     (12,730)                                          -          (12,730)


    Total Select Items                                                                              $1,011                 $(12,730)                                       $2,848                                   $(12,730)
                                                                                                    ======                  ========                                        ======                                    ========


                                                                               Less income tax
                                                                                 effect at 35%                   (354)                                        4,456                                        (997)               4,456


                                                            Select Items
                                                            Impacting
                                                            Earnings, net of
                                                            tax                                                                $657                                      $(8,275)                                     $1,851           $(8,275)


    * Management believes that
     adjusted Net Income for the
     three and twelve months ended
     December 31, 2017, and December
     31, 2016, is useful to investors
     to assess and understand
     operating performance,
     especially when comparing those
     results with previous and
     subsequent periods. Management
     views the expenses associated
     with executive retirement to be
     outside of the Company's normal
     operating results. Management
     analyzes operating results
     without the impact of the above
     items as an indicator of
     performance, to identify
     underlying trends in the
     business and cash flow from
     continuing operations, and to
     establish operational goals.


                                                                Flotek Industries, Inc.

                                   Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

                                                         (in thousands, except per share data)


    GAAP Income (Loss) from Continuing Operations and Reconciliation to Adjusted EBITDA (Non-GAAP)
    ---------------------------------------------------------------------------------------------


                                                                                      Three Months Ended                   Twelve Months Ended
                                                                                      ------------------                   -------------------

                                                               12/31/2017                12/31/2016                12/31/2017                12/31/2016
                                                               ----------                ----------                ----------                ----------

                                                                                              (in thousands, except per share data)


    (Loss) Income from Continuing
     Operations (GAAP)                                           $(7,767)                    $3,917                  $(13,053)                    $1,907


                                     Interest Expense                                           450                        443                      2,168                       1,979


                                     Income Tax Expense                                       9,588                      2,586                      8,842                       1,237


                                      Depreciation and
                                      Amortization                              3,068                      3,049                     12,159                     10,430


    EBITDA (Non-GAAP)                                              $5,339                     $9,995                    $10,116                    $15,553
                                                                   ======                     ======                    =======                    =======


                                     Stock Compensation Expense                               1,493                      3,462                     11,172                      12,053


                                     Loss / (Gain) on Sale of Assets                          (109)                        10                        292                        (18)


                                      Executive Retirement and Severance
                                      Expense                                                 1,011                          -                     1,961                           -


                                     (Gain) on Legal Settlement                                   -                  (12,730)                         -                   (12,730)


    Adjusted EBITDA (Non-GAAP)                                     $7,734                       $737                    $23,541                    $14,858
                                                                   ======                       ====                    =======                    =======


    * Management believes that adjusted EBITDA for the three and twelve months ended December 31, 2017, and December 31, 2016, is useful to investors to assess and understand operating
     performance, especially when comparing those results with previous and subsequent periods. Management views the expenses associated with executive retirement to be outside of the
     Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the
     business and cash flow from continuing operations, and to establish operational goals.


                                                                                                                                                                              Flotek Industries, Inc.

                                                                                                                                                  Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

                                                                                                                                                                       (in thousands, except per share data)


    GAAP Segment Net Income and Reconciliation to Segment Adjusted EBITDA (Non-GAAP)
    -------------------------------------------------------------------------------


                                                             Energy Chemistry Technologies                                        Consumer and Industrial Technologies
                                                             -----------------------------                                        ------------------------------------

                                                              Three Months Ended                    Twelve Months Ended                        Three Months Ended                          Twelve Months Ended
                                                              ------------------                    -------------------                        ------------------                          -------------------

                                                                           12/31/2017                             12/31/2016                                12/31/2017                                   12/31/2016                    12/31/2017              12/31/2016                12/31/2017                  12/31/2016
                                                                           ----------                             ----------                                ----------                                   ----------                    ----------              ----------                ----------                  ----------

                                                        (in thousands, except per share data)                                    (in thousands, except per share data)


    Segment Net Income (GAAP)                                                  $8,896                                  $7,220                                    $33,611                                       $29,014                         $1,559                   $1,156                     $7,465                       $9,664


                 Interest Expense (a)                                                  -                                      -                                         -                                            -                             -                       -                         -                           -


                  Income Tax
                  Expense (a)                          -                                         -                                      -                                           -                                            -                       -                       -                           -


                  Depreciation
                  and
                  Amortization                     1,816                                      1,873                                   7,323                                        5,935                                           640                     572                     2,391                       2,257


    Segment EBITDA (Non-GAAP)                                                 $10,711                                  $9,093                                    $40,934                                       $34,949                         $2,198                   $1,728                     $9,856                      $11,922
                                                                              =======                                  ======                                    =======                                       =======                         ======                   ======                     ======                      =======


                  Stock
                  Compensation
                  Expense                            437                                        519                                   1,946                                        2,278                                            68                      97                       529                         607


                 R&I Allocation                                                    3,535                                   2,997                                     13,130                                         9,319                            169                       0                         515                           1


                  Loss /(Gain) on Sale of
                  Assets                                                           (109)                                     10                                        298                                          (18)                             -                       -                         -                           -


    Segment Adjusted EBITDA (Non-
     GAAP)                                                                    $14,574                                 $12,620                                    $56,308                                       $46,528                         $2,435                   $1,825                    $10,901                      $12,529
                                                                              =======                                 =======                                    =======                                       =======                         ======                   ======                    =======                      =======


    (a) Interest Expense and Tax Expense are recorded at the Corporate level and not allocated to segments.


    * Management believes that adjusted EBITDA for the three and twelve months ended December 31, 2017, and
     December 31, 2016, is useful to investors to assess and understand operating performance, especially
     when comparing those results with previous and subsequent periods. Management views the expenses
     associated with executive retirement to be outside of the Company's normal operating results. Management
     analyzes operating results without the impact of the above items as an indicator of performance, to
     identify underlying trends in the business and cash flow from continuing operations, and to establish
     operational goals.

View original content:http://www.prnewswire.com/news-releases/flotek-industries-inc-announces-fourth-quarter-2017-results-300601524.html

SOURCE Flotek Industries, Inc.